within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J04A_DrugsForTreatmentOfTuberculosis.J04AA02_SodiumAminosalicylate;

model SodiumAminosalicylate
  extends Pharmacolibrary.Drugs.ATC.J.J04AA02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>J04AA02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Sodium aminosalicylate (para-aminosalicylic acid, PAS) is an antibiotic primarily used for the treatment of tuberculosis. It acts as a bacteriostatic agent by inhibiting folic acid synthesis in Mycobacterium tuberculosis. Previously a first-line agent in tuberculosis therapy, it is now mainly used as a second-line drug, especially for multidrug-resistant tuberculosis, owing to the availability of more effective agents. It is not widely used today except in resistant cases.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adults after oral administration.</p><h4>References</h4><ol><li><p>Ryde, EM, &amp; Ahnfelt, NO (1988). The pharmacokinetics of olsalazine sodium in healthy volunteers after a single i.v. dose and after oral doses with and without food. <i>European journal of clinical pharmacology</i> 34(5) 481–488. DOI:<a href=\"https://doi.org/10.1007/BF01046706\">10.1007/BF01046706</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3203708/\">https://pubmed.ncbi.nlm.nih.gov/3203708</a></p></li><li><p>Pooresmaeil, M, &amp; Namazi, H (2021). Developments on carboxymethyl starch-based smart systems as promising drug carriers: A review. <i>Carbohydrate polymers</i> 258 117654–None. DOI:<a href=\"https://doi.org/10.1016/j.carbpol.2021.117654\">10.1016/j.carbpol.2021.117654</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33593542/\">https://pubmed.ncbi.nlm.nih.gov/33593542</a></p></li><li><p>Chen, J, et al., &amp; Xie, F (2018). Starch film-coated microparticles for oral colon-specific drug delivery. <i>Carbohydrate polymers</i> 191 242–254. DOI:<a href=\"https://doi.org/10.1016/j.carbpol.2018.03.025\">10.1016/j.carbpol.2018.03.025</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/29661315/\">https://pubmed.ncbi.nlm.nih.gov/29661315</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end SodiumAminosalicylate;
